Mirum Pharmaceuticals, Inc.
MIRM • NASDAQ • Stock Fundamentals
Mirum Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher Peetz, with a market cap of $6.1B.
Market Cap$6.1B
Employees278.0
CEOChristopher Peetz
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsJul 30, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Mirum Pharmaceuticals, Inc. FAQ
Common questions about Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. (MIRM) has a market capitalization of $6.1B and trades on NASDAQ.
Mirum Pharmaceuticals, Inc. has approximately 278 employees.